Abstract
Lung macrophages present an effective role in innate and immune response through specific and non-specific mechanisms, namely phagocytosis, antigen processing and presentation through major histocompatibility complex, activation of T cells and inflammatory cytokines release. Despite their protective role against injury in normal condition, they can cause several lung conditions, since they can mediate several processes, through recruitment of other inflammatory cells for alveolar space, release of proinflammatory cytokines or stimulation of collagen deposition. Lung macrophages constitute a good therapeutic target. With the development of nanotechnology, new carriers have been designed to target drugs towards these cells. One of the commonly used approaches is the attachment of ligands with affinity to receptors presented at lung macrophage surface, to the nanocarriers. This review will focus on the importance of lung macrophages in host-defense, their influence on different pulmonary diseases and different strategies for alveolar macrophage targeting.
Keywords: Alveolar macrophages, drug delivery systems, ligands, macrophages receptors, mannose receptors, targeting.
Graphical Abstract
Current Drug Targets
Title:Targeted Drug Delivery Systems for Lung Macrophages
Volume: 16 Issue: 14
Author(s): Ana Costa, Bruno Sarmento and Vítor Seabra
Affiliation:
Keywords: Alveolar macrophages, drug delivery systems, ligands, macrophages receptors, mannose receptors, targeting.
Abstract: Lung macrophages present an effective role in innate and immune response through specific and non-specific mechanisms, namely phagocytosis, antigen processing and presentation through major histocompatibility complex, activation of T cells and inflammatory cytokines release. Despite their protective role against injury in normal condition, they can cause several lung conditions, since they can mediate several processes, through recruitment of other inflammatory cells for alveolar space, release of proinflammatory cytokines or stimulation of collagen deposition. Lung macrophages constitute a good therapeutic target. With the development of nanotechnology, new carriers have been designed to target drugs towards these cells. One of the commonly used approaches is the attachment of ligands with affinity to receptors presented at lung macrophage surface, to the nanocarriers. This review will focus on the importance of lung macrophages in host-defense, their influence on different pulmonary diseases and different strategies for alveolar macrophage targeting.
Export Options
About this article
Cite this article as:
Costa Ana, Sarmento Bruno and Seabra Vítor, Targeted Drug Delivery Systems for Lung Macrophages, Current Drug Targets 2015; 16 (14) . https://dx.doi.org/10.2174/1389450115666141114152713
DOI https://dx.doi.org/10.2174/1389450115666141114152713 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
B7-H3 Immune Checkpoint Protein in Human Cancer
Current Medicinal Chemistry Pharmacokinetics-Guided Dosing of 5-Fluorouracil for Precision Cancer Treatment: A Focus on Colorectal Carcinoma
Applied Clinical Research, Clinical Trials and Regulatory Affairs Engineered Liposomes for Drug Delivery and Biomedical Imaging
Recent Patents on Nanomedicine The Anti-Breast Cancer Effects of Green-Synthesized Zinc Oxide Nanoparticles Using Carob Extracts
Anti-Cancer Agents in Medicinal Chemistry Retinoid Related Molecules an Emerging Class of Apoptotic Agents with Promising Therapeutic Potential in Oncology: Pharmacological Activity and Mechanisms of Action
Current Pharmaceutical Design Long Non-Coding RNA GAS5 in Age-Related Diseases
Current Medicinal Chemistry Notch Signalling: A Potential Therapeutic Pathway in Oral Squamous Cell Carcinoma
Endocrine, Metabolic & Immune Disorders - Drug Targets De Novo DNMTs and DNA Methylation: Novel Insights into Disease Pathogenesis and Therapy from Epigenomics
Current Pharmaceutical Design Development of NGR-Based Anti-Cancer Agents for Targeted Therapeutics and Imaging
Anti-Cancer Agents in Medicinal Chemistry Technetium Labeled Small Peptide Radiopharmaceuticals in the Identification of Lung Cancer
Current Pharmaceutical Design Cyclooxygenases in Cancer: Chemoprevention and Sensitization to Conventional Therapies
Mini-Reviews in Medicinal Chemistry Anticancer Mechanisms of Berberine: A Good Choice for Glioblastoma Multiforme Therapy
Current Medicinal Chemistry EMT Blockage Strategies: Targeting Akt Dependent Mechanisms for Breast Cancer Metastatic Behaviour Modulation
Current Gene Therapy Detection of Squamous Cell Carcinoma Antigen with Micro- and Nanogap Interdigitated Electrodes and Gold Nanoparticles
Micro and Nanosystems Functionalized Nanocarriers for Enhanced Bioactive Delivery to Squamous Cell Carcinomas: Targeting Approaches and Related Biopharmaceutical Aspects
Current Pharmaceutical Design Current Application of Quantum Dots (QD) in Cancer Therapy: A Review
Mini-Reviews in Medicinal Chemistry The Immunohistochemical Assessment of HPV Related Adenocarcinoma: Pathologic and Clinical Prognostic Significance
Current Pharmaceutical Design Targeting Ras-RAF-ERK and its Interactive Pathways as a Novel Therapy for Malignant Gliomas
Current Cancer Drug Targets Advanced Neoplastic Disease as Immunologic, Endocrine and Metabolic Disorder
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Oncolytic Virotherapy for Breast Cancer Treatment
Current Gene Therapy